SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]
SEC Accession No. 0001562180-20-004695
Filing Date
2020-06-25
Accepted
2020-06-25 16:59:46
Documents
2
Period of Report
2020-06-23

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primarydocument.html 4/A  
1 PRIMARY DOCUMENT primarydocument.xml 4/A 4145
2 MAYA SAID - POWER OF ATTORNEY said-16poa.txt EX-24 3483
  Complete submission text file 0001562180-20-004695.txt   9145
Mailing Address 255 STATE STREET 9TH FLOOR BOSTON MA 02109
Business Address 255 STATE STREET 9TH FLOOR BOSTON MA 02109 857-246-8998
PIERIS PHARMACEUTICALS, INC. (Issuer) CIK: 0001583648 (see all company filings)

IRS No.: 300784346 | State of Incorp.: NV | Fiscal Year End: 1231
SIC: 8731 Services-Commercial Physical & Biological Research

Mailing Address C/O PIERIS PHARMACEUTICALS, INC. 255 STATE STREET, 9TH FLOOR BOSTON MA 02109
Business Address
Said Maya R. (Reporting) CIK: 0001783701 (see all company filings)

Type: 4/A | Act: 34 | File No.: 001-37471 | Film No.: 20989964